Beneficient filed a Form 8-K on October 28, 2026, disclosing that the company and certain subsidiaries filed a motion to intervene in a Delaware Court of Chancery case brought by HCLP Nominees, L.L.C. against Delaware Trust Company, as part of the company's stated strategy to eliminate what it characterizes as fraudulent indebtedness and related equity interests.

Key Highlights

  • Motion to intervene: Beneficient and certain subsidiaries filed a motion to intervene in Delaware Court of Chancery litigation previously brought by HCLP Nominees, L.L.C. against Delaware Trust Company.
  • Relief sought: According to the filing, the motion seeks to invalidate the HCLP credit agreements and related loan documents and cancel the purported obligations.
  • Recovery target: The filing states the company seeks to recover approximately $211 million previously paid on the purported debt.
  • Collateral dispute: The company seeks to establish, according to the filing, that HCLP has no valid right to the related collateral.
  • Former CEO involvement: The company disclosed it is also seeking to eliminate equity interests held by former Chief Executive Officer Brad Heppner and his affiliated entities.
  • Regulation FD: The disclosure was made under Item 7.01, and the filing notes it "shall not be deemed to be 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934."

Beneficient Pursues Strategy to Invalidate HCLP Debt and Heppner-Linked Interests

Beneficient (NASDAQ:BENF), a Nevada-incorporated company headquartered in Dallas, Texas, reported on October 28, 2026, that it and certain subsidiaries have filed a motion to intervene in an existing Delaware Court of Chancery proceeding. That litigation was originally brought by HCLP Nominees, L.L.C. against Delaware Trust Company. The current report was signed by Chief Financial Officer Gregory W. Ezell.

According to the filing, the company "has formulated and is implementing a comprehensive strategy intended to eliminate both the fraudulent indebtedness asserted by HCLP and the equity interests in the Company and its subsidiaries held by the Company's former Chief Executive Officer, Brad Heppner, and his affiliated entities." The motion to intervene is described as furthering that strategy. Specifically, the filing states the company is seeking to invalidate the HCLP credit agreements and related loan documents, cancel the purported obligations, and recover approximately $211 million previously paid on what the company characterizes as purported debt.

The company also disclosed that the filing contains forward-looking statements, which, according to the company's own cautionary language, "are subject to risks and uncertainties, many of which are outside of our control." Identified risks include the possibility that litigation outcomes and timing may not be favorable, that a consensual resolution with Mr. Heppner may not be achievable, and disputes concerning the validity, enforceability, and amount of the HCLP claims. A press release was attached as Exhibit 99.1 and incorporated by reference.

What Was Disclosed

Beneficient reported the filing of a motion to intervene in Delaware Court of Chancery litigation involving HCLP Nominees, L.L.C. and Delaware Trust Company, seeking to invalidate HCLP debt agreements, recover approximately $211 million, and cancel related collateral rights, as part of a broader strategy targeting former CEO Brad Heppner's affiliated interests.